Norges Bank purchased a new position in shares of Cabot Corp (NYSE:CBT) during the fourth quarter, HoldingsChannel reports. The firm purchased 799,087 shares of the specialty chemicals company’s stock, valued at approximately $34,313,000.
A number of other hedge funds have also modified their holdings of CBT. Lindbrook Capital LLC purchased a new position in Cabot during the fourth quarter worth approximately $28,000. Meeder Asset Management Inc. boosted its position in Cabot by 28.2% during the fourth quarter. Meeder Asset Management Inc. now owns 1,049 shares of the specialty chemicals company’s stock worth $45,000 after purchasing an additional 231 shares in the last quarter. IFP Advisors Inc boosted its position in Cabot by 723.5% during the fourth quarter. IFP Advisors Inc now owns 1,087 shares of the specialty chemicals company’s stock worth $46,000 after purchasing an additional 955 shares in the last quarter. Bremer Trust National Association purchased a new position in Cabot during the fourth quarter worth approximately $50,000. Finally, Ipswich Investment Management Co. Inc. purchased a new position in shares of Cabot in the fourth quarter valued at approximately $79,000. Institutional investors own 86.61% of the company’s stock.
CBT has been the topic of several research reports. TheStreet upgraded Cabot from a “c” rating to a “b-” rating in a research report on Tuesday, February 5th. Zacks Investment Research downgraded Cabot from a “hold” rating to a “sell” rating in a research report on Monday, February 4th. Finally, ValuEngine downgraded Cabot from a “sell” rating to a “strong sell” rating in a research report on Tuesday, February 5th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the stock. Cabot has a consensus rating of “Buy” and an average target price of $74.80.
NYSE CBT opened at $47.36 on Wednesday. The company has a market capitalization of $2.76 billion, a PE ratio of 11.75, a PEG ratio of 1.00 and a beta of 1.37. Cabot Corp has a 1-year low of $39.57 and a 1-year high of $67.80. The company has a current ratio of 1.31, a quick ratio of 0.75 and a debt-to-equity ratio of 0.53.
Cabot (NYSE:CBT) last released its earnings results on Monday, February 4th. The specialty chemicals company reported $0.87 earnings per share for the quarter, missing the consensus estimate of $0.90 by ($0.03). The firm had revenue of $821.00 million during the quarter, compared to analysts’ expectations of $778.50 million. Cabot had a net margin of 2.33% and a return on equity of 19.05%. The business’s revenue was up 14.0% compared to the same quarter last year. During the same quarter last year, the business earned $0.93 EPS. On average, research analysts predict that Cabot Corp will post 4.39 earnings per share for the current fiscal year.
WARNING: “Norges Bank Takes $34.31 Million Position in Cabot Corp (CBT)” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another domain, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this article can be accessed at https://www.dispatchtribunal.com/2019/04/17/norges-bank-takes-34-31-million-position-in-cabot-corp-cbt.html.
Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber.
Featured Story: Can individual investors take part in an IPO?
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corp (NYSE:CBT).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.